Correlation Between Salesforce and SCI Pharmtech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and SCI Pharmtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and SCI Pharmtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and SCI Pharmtech, you can compare the effects of market volatilities on Salesforce and SCI Pharmtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of SCI Pharmtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and SCI Pharmtech.

Diversification Opportunities for Salesforce and SCI Pharmtech

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Salesforce and SCI is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and SCI Pharmtech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCI Pharmtech and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with SCI Pharmtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCI Pharmtech has no effect on the direction of Salesforce i.e., Salesforce and SCI Pharmtech go up and down completely randomly.

Pair Corralation between Salesforce and SCI Pharmtech

Considering the 90-day investment horizon Salesforce is expected to generate 2.17 times more return on investment than SCI Pharmtech. However, Salesforce is 2.17 times more volatile than SCI Pharmtech. It trades about 0.32 of its potential returns per unit of risk. SCI Pharmtech is currently generating about 0.28 per unit of risk. If you would invest  27,044  in Salesforce on August 25, 2024 and sell it today you would earn a total of  7,158  from holding Salesforce or generate 26.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy97.78%
ValuesDaily Returns

Salesforce  vs.  SCI Pharmtech

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
SCI Pharmtech 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in SCI Pharmtech are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, SCI Pharmtech may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Salesforce and SCI Pharmtech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and SCI Pharmtech

The main advantage of trading using opposite Salesforce and SCI Pharmtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, SCI Pharmtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCI Pharmtech will offset losses from the drop in SCI Pharmtech's long position.
The idea behind Salesforce and SCI Pharmtech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stocks Directory
Find actively traded stocks across global markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets